Increase in nucleoli after x-radiation of fibroblasts of patients with Gorlin syndrome

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 6, 1999, Pages 585-591

  Dezawa, Mari ^a   Fujii, Katsunori ^b   Kita, Kazuko ^b   Nomura, Jun ^b   Sugita, Katsuo ^b   Adachi Usami, Emiko ^b   Suzuki, Nobuo ^b  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033486140     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90097-5     Document Type: Article

References (29)

1. 1. Gorlin RJ, Golts RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 1962; 262:908-12.
2. 2. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine 1987;66:98-113.
3. 3. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Dermatol Clin 1995;13:113-25.
4. 4. Springate JE. The nevoid basal cell carcinoma syndrome. J Pediatr Surg 1986;21:908-10.
5. 5. Evans DGR, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon PA. Complications of the nevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993;30:460-4.
6. 6. Farndon PA, Del Mastro RG, Evans DGR, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet 1992; 339:581-2.
7. 7. Gailani MR, Bale SJ, Leffell DJ, DiGiovanna JJ, Peck GL, Poliak S, et al. Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell 1992;69:111-7.
8. 8. Reis A, Kuster W, Linss G, Gustafson G, Kuklik M, Burger J, et al. Location of gene for the naevoid basal-cell carcinoma syndrome. Lancet 1992;339:617.
9. 9. Shanley SM, Dawkins H, Wainwright BJ, Wicking C, Heenan P, Eldon M, et al. Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. Hum Mol Genet 1995;4:129-33.
10. 10. Gailani MR, Leffell DJ, Ziegler AM, Gross EG, Brash DE, Bale AE. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J Natl Cancer Inst 1996;88:349-54.
11. 11. Holmberg E, Lundh-Rozell B, Toftgard R. Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer. Br J Cancer 1996;74:246-50.
12. 12. Strong LC. Theories of pathogenesis: mutation and cancer. In: Mulvihill JJ, Miller RW, Fraumeni JF, editors. Genetics of human cancer. New York: Raven Press, 1977. p 401-5.
13. 13. Featherstone T, Taylor AMR, Harnden DG. Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am J Human Genet 1983;35:58-66.
14. 14. Fujii K, Suzuki N, Ishijima S, Kita K, Sonoda T, Dezawa M, et al. Abnormal DNA synthesis activity induced by x-rays in nevoid basal cell carcinoma cells. Biochem Biophys Res Commun 1997;240:269-72.
15. 15. Sugita K, Suzuki N, Fujii K, Niimim H. Reduction of unscheduled DNA synthesis and plasminogen activator in HutchinsonGilford fibroblasts during passaging in vitro: partial correction by interferon-β. Mutat Res 1995;316:133-8.
16. 16. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971;2:971-2.
17. 17. Dezawa M, Nagano T. Immunohistochemical localization of cell adhesion molecules and cell-cell contact proteins during regeneration of the rat optic nerve induced by sciatic nerve autotransplation. Anat Rec 1996;246:114-26.
18. 18. Miller OL. The nucleolus, chromosomes, and visualization of genetic activity. J Cell Biol 1981;91:15s-27s.
19. 19. Mourad WA, Erkman-Balis B, Livingston S, Shoukri M, Cox C, Nicosia S, et al. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status. Cancer 1992;69: 1739-44.
20. 20. Spector DL. Nuclear organization of pre-mRNA processing. Curr Opin Cell Biol 1993;5:442-7.
21. 21. Guthrie C. Messenger RNA splicing in yeast: clues to why the spliceosome is a ribonucleoprotein. Science 1991;253: 157-63.
22. 22. Dreyfuss G, Swanson MS, Pinol-Roma S. Heterogeneous nuclear ribonucleoprotein particles and the pathway of mRNA formation. Trends Biochem Sci 1988;13:86-91.
23. 23. Ramsamooj P, Notario V, Dritschilo A. Modification of nucleolar protein B23 after exposure to ionizing radiation. Radiat Res 1995;143:158-64.
24. 24. Orkisz S, Bartel H. Morphology of nuclear ribonucleoproteins in the early period of liver regeneration after irradiation. Histochem 1981;71:629-34.
25. 25. Scott WA, Tomkins GM. The use of inhibitors in the study of hormone mechanisms in cell culture. In: Malley BWO, Hardmanm JG, editors. Methods in enzymology (vol 40). London: Academic Press, 1975. p 273-93.
26. 26. Gyesko A, Holezinger L. Changes in nucleolar number of ascites tumor cells treated with actinomycin D. Neoplasma 1975;22:395-402.
27. 27. Kramer B. The effect of actinomycin D on the nucleolus and on pigment synthesis in pigment cells of Xenopus laevis: an ultrastructural study. J Anat 1980;130:809-20.
28. 28. Hall PA, Crocker J, Watts A, Stansfield AG. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology 1988; 12:373-81.
29. 29. Moran K, Cooke T, Forster G, Gillen P, Sheehan S, Dervan P, et al. Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer. Br J Surg 1989;76:1152-5.